Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
Home
About Us
Management Team
Board of Directors
Investors
Press Releases
Events & Presentations
Proxy Materials
SEC Filings
Corporate Governance
Management Team
Board of Directors
Committee Composition
Stock Information
Historic Stock Lookup
Analysts
Shareholder Tools
Shareholder Briefcase
Email Alerts
Careers
Contact
For more information, please click here »
News & Events
Wednesday, May 8, 2013
Transcept Pharmaceuticals Reports First Quarter 2013 Financial Results
Wednesday, May 1, 2013
Transcept Pharmaceuticals to Report First Quarter 2013 Financial Results and Host Conference Call on May 8, 2013
Wednesday, April 10, 2013
Thomas J. Dietz, Ph.D., Appointed To The Transcept Pharmaceuticals Board Of Directors
Thursday, February 28, 2013
Transcept Pharmaceuticals to Present at Cowen and Company Health Care Conference on March 6